Article

Anjee Davis on the Future of Research and Advocacy in Colorectal Cancer

Author(s):

Anjee Davis

Anjee Davis, president, Fight Colorectal Cancer, discusses the future of research in colorectal cancer and the importance of research advocates.

Anjee Davis, president, Fight Colorectal Cancer, discusses the future of research in colorectal cancer and the importance of research advocates. We spoke with Davis at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago in May and June.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Minimally Invasive Surgery Transforms Lung Cancer Recovery
Image of woman with text.
Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Image of man with text.
Image of woman with text.
Image of man with text.
Image of Staci.
Image of woman, with text.
Related Content
Carla Deschamps is now a survivor of colon cancer after receiving her diagnosis in February 2020. Read Carla's blogs here!
August 2nd 2025

Can Journaling Help Heal After a Cancer Diagnosis?

Carla Deschamps
Writing helped me focus on gratitude and healing after my colon cancer diagnosis, transforming the act into a powerful recovery tool.
Teri Greige with medals
August 2nd 2025

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
Photo of a person with an illustrated gastrointestinal tract in front of them
August 2nd 2025

Zanzalintinib Combo Improves Survival in Metastatic Colorectal Cancer

Spencer Feldman
Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic colorectal cancer, phase 3 data show.
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
August 2nd 2025

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Braftovi and Erbitux plus chemo improved survival without progression over standard therapy in BRAF V600E-mutant mCRC in the first-line setting: © stock.adobe.com.
August 2nd 2025

Braftovi and Erbitux Plus Chemo Improves Outcomes for BRAF V600E+ mCRC

Chris Ryan
Braftovi and Erbitux plus chemotherapy improved survival without progression over standard therapy in BRAF V600E-mutant mCRC in the first-line setting.
Image of intestines.
August 2nd 2025

Acoustic Cluster Therapy Shows Benefit in Colorectal Liver Metastases

Spencer Feldman
Tumors shrank more with the addition of acoustic cluster therapy to chemotherapy in colorectal liver metastases in the phase 1 ACTIVATE trial.